Subtype
Intermediate Fibroblastic Neoplasm
CI-CAN-00001015Explore in graph →
Non-malignant31 active trials31 evidence items
- NCIt
- C7333
Loading cancer entity…
Subtype
CI-CAN-00001015Explore in graph →
Clinical trials
128 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT07227649 | NAC-REPAIR for Post-surgical Pain | not yet recruiting | Phase 2 | 80 | University of ArizonaOTHER | 1 | Jul 17, 2026 | clinicaltrials |
| NCT07646080 | Exploratory Study on Toripalimab and Anlotinib Combined With Standard Chemotherapy for Refractory Dermatofibrosarcoma Protuberans | not yet recruiting | Phase 2 | 20 | Yanjie Zhang, MDOTHER | 0 | Jun 16, 2026 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jul 17, 2026source: clinicaltrials